1. Home
  2. VIGL vs GAIA Comparison

VIGL vs GAIA Comparison

Compare VIGL & GAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIGL
  • GAIA
  • Stock Information
  • Founded
  • VIGL 2020
  • GAIA 1988
  • Country
  • VIGL United States
  • GAIA United States
  • Employees
  • VIGL N/A
  • GAIA N/A
  • Industry
  • VIGL Biotechnology: Pharmaceutical Preparations
  • GAIA Movies/Entertainment
  • Sector
  • VIGL Health Care
  • GAIA Consumer Discretionary
  • Exchange
  • VIGL Nasdaq
  • GAIA Nasdaq
  • Market Cap
  • VIGL 125.3M
  • GAIA 121.5M
  • IPO Year
  • VIGL 2022
  • GAIA 1999
  • Fundamental
  • Price
  • VIGL $3.51
  • GAIA $5.15
  • Analyst Decision
  • VIGL Buy
  • GAIA
  • Analyst Count
  • VIGL 5
  • GAIA 0
  • Target Price
  • VIGL $16.60
  • GAIA N/A
  • AVG Volume (30 Days)
  • VIGL 98.4K
  • GAIA 34.5K
  • Earning Date
  • VIGL 11-05-2024
  • GAIA 10-28-2024
  • Dividend Yield
  • VIGL N/A
  • GAIA N/A
  • EPS Growth
  • VIGL N/A
  • GAIA N/A
  • EPS
  • VIGL N/A
  • GAIA N/A
  • Revenue
  • VIGL N/A
  • GAIA $84,711,000.00
  • Revenue This Year
  • VIGL N/A
  • GAIA $14.65
  • Revenue Next Year
  • VIGL N/A
  • GAIA $20.63
  • P/E Ratio
  • VIGL N/A
  • GAIA N/A
  • Revenue Growth
  • VIGL N/A
  • GAIA 7.27
  • 52 Week Low
  • VIGL $2.47
  • GAIA $2.35
  • 52 Week High
  • VIGL $9.24
  • GAIA $5.35
  • Technical
  • Relative Strength Index (RSI)
  • VIGL 53.88
  • GAIA 60.40
  • Support Level
  • VIGL $3.30
  • GAIA $4.57
  • Resistance Level
  • VIGL $3.60
  • GAIA $4.83
  • Average True Range (ATR)
  • VIGL 0.16
  • GAIA 0.18
  • MACD
  • VIGL 0.02
  • GAIA 0.01
  • Stochastic Oscillator
  • VIGL 81.63
  • GAIA 87.59

About VIGL Vigil Neuroscience Inc.

Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families. Its clinical candidate, iluzanebart, is currently being studied in IGNITE, a Phase 2 PoC trial and the first-ever interventional trial in ALSP patients. The company is also developing VG-3927, an orally available small molecule TREM2 agonist for the treatment of common neurodegenerative diseases associated with microglial dysfunction.

About GAIA Gaia Inc.

Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. Geographically, it derives a majority of its revenue from the United States and also has an international presence.

Share on Social Networks: